DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway.

"Declarations Ethical statementInformed consent was obtained from all subjects involved in the study. Ethics approval was obtained from the Second Affiliated Hospital of Wenzhou Medical University regarding the procedure related to human subjects (KY2022-K-146-01). Animal research has been approved by the Animal Ethics Committee of Wenzhou Medical University (wydw2022-0587) and all methods were reported in accordance with ARRIVE guidelines. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by Zhejiang Key Laboratory of Traditional Chinese Medicine for Diagnosis and Treatment of Gynecological Cancers (2022-11)."